Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1352)
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,636
Price
$68.38
Total Value
$111.88K
Shares Held After
39,029
% of Holdings
4.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
395
Price
$69.69
Total Value
$27.53K
Shares Held After
16,899
% of Holdings
2.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.46
Total Value
$528.45K
Shares Held After
385,330
% of Holdings
1.9%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
6,250
Price
$35.08
Total Value
$219.22K
Shares Held After
793
% of Holdings
88.7%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
11,322
Price
$0.40
Total Value
$4.53K
Shares Held After
349,907
% of Holdings
3.1%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
159,119
Price
$0.40
Total Value
$63.65K
Shares Held After
4,917,566
% of Holdings
3.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
391,019
Price
$8.57
Total Value
$3.35M
Shares Held After
16,622,736
% of Holdings
2.4%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
19,842
Price
$74.05
Total Value
$1.47M
Shares Held After
22,458
% of Holdings
46.9%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
41,004
Price
$73.09
Total Value
$3.00M
Shares Held After
42,300
% of Holdings
49.2%
Travere Therapeutics, Inc. (TVTX)
Coughlin Timothy — Director
Shares
10,000
Price
$50.07
Total Value
$500.75K
Shares Held After
56,250
% of Holdings
15.1%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
4,500
Price
$50.00
Total Value
$225.00K
Shares Held After
41,500
% of Holdings
9.8%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
13,095
Price
$72.15
Total Value
$944.86K
Shares Held After
1,065,135
% of Holdings
1.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
97,954
Price
$71.37
Total Value
$6.99M
Shares Held After
1,078,230
% of Holdings
8.3%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
4,252,767
Price
$0.02
Total Value
$68.04K
Shares Held After
2,459,308
% of Holdings
172.9%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
2,102
Price
$3.36
Total Value
$7.06K
Shares Held After
106,675
% of Holdings
1.9%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
21,000
Price
$2.50
Total Value
$52.50K
Shares Held After
630,812
% of Holdings
3.3%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
12,996
Price
$3.94
Total Value
$51.20K
Shares Held After
136,381
% of Holdings
8.7%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
3,461
Price
$256.08
Total Value
$886.29K
Shares Held After
4,981
% of Holdings
41.0%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
3,000
Price
$255.01
Total Value
$765.03K
Shares Held After
8,442
% of Holdings
26.2%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Senderowicz Adrian — Director
Shares
27,000
Price
$7.20
Total Value
$194.31K
Shares Held After
27,000
% of Holdings
50.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Stuglik Brian M — Director
Shares
8,100
Price
$7.20
Total Value
$58.31K
Shares Held After
113,858
% of Holdings
6.6%
PUMA BIOTECHNOLOGY, INC. (PBYI)
MOYES JAY M — Director
Shares
22,000
Price
$7.22
Total Value
$158.80K
Shares Held After
58,322
% of Holdings
27.4%
PUMA BIOTECHNOLOGY, INC. (PBYI)
WILSON TROY EDWARD — Director
Shares
10,800
Price
$7.20
Total Value
$77.75K
Shares Held After
59,750
% of Holdings
15.3%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
1,654
Price
$2.23
Total Value
$3.69K
Shares Held After
505,094
% of Holdings
0.3%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
2,584
Price
$2.23
Total Value
$5.77K
Shares Held After
512,319
% of Holdings
0.5%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Dorval Allison — Director
Shares
11,610
Price
$7.20
Total Value
$83.58K
Shares Held After
90,780
% of Holdings
11.3%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,260
Price
$70.34
Total Value
$229.31K
Shares Held After
17,294
% of Holdings
15.9%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,340
Price
$69.85
Total Value
$303.15K
Shares Held After
20,554
% of Holdings
17.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
1,859
Price
$68.34
Total Value
$127.05K
Shares Held After
24,894
% of Holdings
6.9%
FRACTYL HEALTH, INC. (GUTS)
Royan Ajay — Director
Shares
23,000
Price
$0.85
Total Value
$19.60K
Shares Held After
40,901
% of Holdings
56.2%
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
DOW GEOFFREY S — Director
Shares
7,350
Price
$1.38
Total Value
$10.13K
Shares Held After
24,131
% of Holdings
30.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
743
Price
$545.71
Total Value
$405.46K
Shares Held After
40,513
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$544.45
Total Value
$304.89K
Shares Held After
41,256
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$543.03
Total Value
$130.33K
Shares Held After
41,816
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,797
Price
$542.40
Total Value
$974.69K
Shares Held After
42,056
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,671
Price
$541.23
Total Value
$904.39K
Shares Held After
43,853
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,154
Price
$540.46
Total Value
$1.70M
Shares Held After
45,524
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
535
Price
$539.24
Total Value
$288.49K
Shares Held After
48,678
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$538.43
Total Value
$215.91K
Shares Held After
49,213
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$537.40
Total Value
$214.42K
Shares Held After
49,614
% of Holdings
0.8%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
5,000
Price
$1.77
Total Value
$8.85K
Shares Held After
10,100
% of Holdings
49.5%
Tonix Pharmaceuticals Holding Corp. (TNXP)
Taylor Carolyn E. — Director
Shares
1,415
Price
$10.55
Total Value
$14.93K
Shares Held After
1,833
% of Holdings
77.2%
ARS Pharmaceuticals, Inc. (SPRY)
Karas Eric — Chief Commercial Officer
Shares
25,000
Price
$10.00
Total Value
$250.00K
Shares Held After
12,176
% of Holdings
67.2%
ARS Pharmaceuticals, Inc. (SPRY)
Fitzpatrick Alexander A — Chief Legal Officer
Shares
3,355
Price
$10.00
Total Value
$33.55K
Shares Held After
90,910
% of Holdings
3.6%
Alkermes plc. (ALKS)
Wright Christopher I — Director
Shares
2,000
Price
$45.10
Total Value
$90.20K
Shares Held After
25,680
% of Holdings
7.2%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
12,583
Price
$70.11
Total Value
$882.18K
Shares Held After
38,743
% of Holdings
24.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,349
Price
$23.93
Total Value
$151.90K
Shares Held After
63,443
% of Holdings
9.1%
Syndax Pharmaceuticals Inc (SNDX)
Botwood Nicholas A.J. — Head of R&D, CMO
Shares
31,235
Price
$18.14
Total Value
$566.60K
Shares Held After
60,885
% of Holdings
33.9%
Summit Therapeutics Inc. (SMMT)
Zanganeh Mahkam — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Summit Therapeutics Inc. (SMMT)
DUGGAN ROBERT W — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Showing 551–600 of 1352 transactions (page 12 of 28)